NEALS 30-Year Impact Report

Member Sites Powering Innovation in ALS Trials

PLATFORM TRIALS With NEALS-led training and infrastructure, sites helped launch the HEALEY ALS Platform Trial , the first-ever platform trial for ALS . Their early adoption of adaptive protocols enabled faster trial launches and shared learning across therapeutic regimens.

Learn more:

Bringing ideas & innovation to ALS research

CLINICAL TRIAL MATCHING Through Healey ALS MyMatch , member sites assist with screening and enrollment into a centralized registry that helps

Learn more:

match people living with ALS to eligible clinical trials — both within and outside the Platform Trial.

DATA AND BIOSAMPLE SHARING (ALL ALS) Participating NEALS sites contribute critical biospecimens, digital health measures, clinical data, and patient-reported outcomes to the ALL ALS Consortium , a collaborative initiative building a robust dataset to support biomarker discovery and a deeper understanding of ALS subtypes.

Learn more:

22

Made with FlippingBook interactive PDF creator